PRODUCTS & SYSTEMS · 12 AUGUST 2026 · RELEASE WITHHELD
On 12 August 2026, the Everyday Hanbang data package passed validation and its public-release check failed. That failure was correct. The gate was designed to stay closed while human review, audience testing, a final URL, name clearance and asset rights were missing.
Everyday Hanbang was a working title for an information site aimed at international readers. The idea was to start with familiar skincare labels, Korean food and drinks, then show where they touch Korean medicine without treating a shared name or ingredient as evidence of efficacy. A review build and release package survived; the site did not launch.
31
Source records
33
Atomic claims
Eight locales
Critical UI-copy drafts
Zero audience results
Site-specific pilot not run
Beginning with skin, plate and cup
The review build used three gateways: Skin · Plate · Cup. A reader could begin with an ingredient label, a food such as yakgwa or a drink associated with ssanghwa, then move through identity, cultural connection, modern evidence and safety as separate layers.
The editorial boundary mattered more than the visual hook. A cosmetic, drink or dessert does not become medicine because a name or ingredient overlaps. Traditional records are not clinical efficacy evidence. Evidence for an orally consumed raw ingredient cannot simply be transferred to a topical or finished product.
A coherent package, not a cleared publication
The handoff bundle contained 31 source records, 33 atomic claims, four ingredient passports, one formula, one cultural record and seven encounters. Schemas connected sources, claims, entities and destinations. `npm run validate` resolved every reference and parsed the JSON successfully.
That result showed that the package agreed with itself. It did not establish that every medical sentence had been reviewed or that an international reader would understand the distinctions. Public release therefore had its own gate.
The blockers were larger than a code fix
The first was the source itself. The handoff workspace held deployed snapshots, but the editable source repository had not been recovered. There was no approved HTTPS origin, so canonical, social and hreflang metadata still pointed to localhost:3000. Indexing rules also needed to distinguish a private review build from an approved public build.
Human review was missing. Six additional locale drafts contained machine-drafted critical interface copy, with no named reviewers. I left those routes out of the public state instead of promoting a translation because the file existed.
The site-specific international audience pilot had not run either. Broad interest in Korean food and beauty was only background context. A small test beginning with 12 adults had been planned, but there were no participants, responses or percentages to report for this site.
The working title and logo still needed a conflict check. The main still-life image in the review snapshot had no recovered creator or licence record, so the asset register explicitly barred it from a public build.
A health-information draft carries a different cost of ambiguity
Two encounter cards were still labelled as drafts rather than public facts, and some quiz choices did not lead to source-backed connection records. Common names also risked being read as exact matches even when species, plant part, processing, dose or route had not been established.
I could have put the review build online and repaired those gaps later. The likely misunderstanding, however, concerned health claims and identity rather than a harmless missing button. Without reviewers for evidence, safety language and translation, withholding release was the defensible outcome.
What remains is a restart point
There is no public URL, user count, usage metric or revenue to claim. The validated records are internal assets, not product adoption. What survives is a release package that states exactly why the site remained private and what would have to change before another attempt.
A restart would begin with source recovery and title and asset clearance. English and Korean evidence and safety copy would need human review next. Only after real international readers could distinguish cultural connection from medical effect would the public gate be worth running again.
Project record
Reference package: 12 August 2026
Working title: Everyday Hanbang — title and logo not cleared
Intended audience: international general readers encountering Korean food, drink and skincare
Internal outcome: 31 source records, 33 claims, schema and reference validation passed, fail-closed release gate
Final status: public release withheld
External validation or product outcome: no site-specific audience study, public users, usage metrics or revenue
Primary blockers: source recovery, final URL, human language and fact review, audience pilot, name/logo clearance and asset rights